Abstract

The increasing incidence of implant-associated infections has prompted the development of effective strategies to prevent biofilm formation on these devices. In this work, pristine graphene nanoplatelet/polydimethylsiloxane (GNP/PDMS) surfaces containing different GNP loadings (1, 2, 3, 4, and 5 wt%) were produced and evaluated on their ability to mitigate biofilm development. After GNP loading optimization, the most promising surface was tested against single- and dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. The antibiofilm activity of GNP/PDMS surfaces was determined by the quantification of total, viable, culturable, and viable but nonculturable (VBNC) cells, as well as by confocal laser scanning microscopy (CLSM). Results showed that 5 wt% GNP loading reduced the number of total (57%), viable (69%), culturable (55%), and VBNC cells (85%) of S. aureus biofilms compared to PDMS. A decrease of 25% in total cells and about 52% in viable, culturable, and VBNC cells was observed for P. aeruginosa biofilms. Dual-species biofilms demonstrated higher resistance to the antimicrobial activity of GNP surfaces, with lower biofilm cell reductions (of up to 29% when compared to single-species biofilms). Still, the effectiveness of these surfaces in suppressing single- and dual-species biofilm formation was confirmed by CLSM analysis, where a decrease in biofilm biovolume (83% for S. aureus biofilms and 42% for P. aeruginosa and dual-species biofilms) and thickness (on average 72%) was obtained. Overall, these results showed that pristine GNPs dispersed into the PDMS matrix were able to inhibit biofilm growth, being a starting point for the fabrication of novel surface coatings based on functionalized GNP/PDMS composites.

Highlights

  • IntroductionImplantable medical devices (IMDs) play an active role in the therapy of different medical conditions, enhancing the quality of life [1,2]

  • As particle morphology affects the microstructure and porosity of nanocomposites, the characterization of the graphene sample is of extreme importance [57]

  • The physisorption isotherms obtained are in accordance with those described in previous reports on pristine graphenenanoplatelets nanoplatelets (GNPs) [59,60]

Read more

Summary

Introduction

Implantable medical devices (IMDs) play an active role in the therapy of different medical conditions, enhancing the quality of life [1,2]. They are extremely successful in supporting or even replacing damaged body organs, IMDs (e.g., cardiac implantable devices, hemodialyzers, urinary or central venous catheters, contact lenses, artificial breasts, and orthodontal and orthopedic prosthetics) carry the risk of inducing future infections, seriously affecting the patients’ health and even endangering their lives [3,4,5]. Implantassociated infections (IAIs) present a high incidence, corresponding to 60–70% of the nosocomial infections reported each year in the United States [6], and are responsible for a severe burden on healthcare systems and high economic costs [7,8].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call